腹水浓缩回输术治疗肝硬化腹水40例效果评价

Abstract
Figure/Table
References (15)
Related Citation (0)

Download: PDF (0 KB) HTML (40 KB)
Export: BibTeX | EndNote (RIS)

Abstract ObjectiveTo study the treatment effect of concentration back to lose of 40 patients with cirrhotic ascites.Methods80 patients with liver cirrhosis ascites in our hospital from February 2015 to January 2016 were selected and divided into group A and group B,with 40 cases in each group.Patients of two groups were given dieresis and protect liver treatment,on the basis of conventional treatment,group A was given multiple therapeutic abdomen through dispersing treatment;on the basis of conventional treatment,group B was given the treatment of ascites concention doping,ultrafiltration volume was 4000-10 000 ml each time,treatment time control in 1.5-3.0 h,1 time/week.The liver cirrhosis ascites weight, 6,24 hour urine,blood serum protein,glomerular filtration rate and 24 hours urinary sodium concentration before and after treatment and clinical curative effect after treatment of patients in the two groups were observed.ResultsIn 4 weeks after treatment,weight of B group was(64.87±6.23)kg,abdominal girth was(64.14±7.14)cm,urine volume in 24 hours was(1487.87±401.41)ml,were superior to those of the group A(P＜0.05);the serum ALB was(31.71±5.23)g/L, glomerular filtration rate was(67.14±14.80)ml/min and 24 hours urinary sodium concerntration was(72.87±10.03)mmol/L, were higher than those of the group A(P＜0.05);Cys concention was(1.24±0.23)mg/L,was lower than those in group A (P＜0.05),the total effective rate of group B was 85.00%,higher than that of group A(P＜0.05).ConclusionThe ascites cercention doping technique for the treatment of ascites significantly is worth popularizing in clinical implementation.

Key words： Ascites concentration doping technique Liver cirrhosis ascites Liver and kidney function

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	WU hao
	TANG Wu
	PENG Bao-gang

Cite this article:

WU hao,TANG Wu,PENG Bao-gang. The effect assessment of ascites concentrated transfusion in the treatment of 40 cases of cirrhotic ascites[J]. 中国当代医药, 2017, 24(15): 31-33.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2017/V24/I15/31

[1]	郭永青.腹水浓缩回输腹腔治疗肝硬化腹水的应用和护理[J].中外医疗，2012，31（32）：137-137.
[2]	文正燕.奥曲肽联合腹水浓缩回输在肝硬化腹水诊治中的临床观察[J].中国民康医学，2014，26（11）：20-22.
[3]	张凤英.恩替卡韦联合腹水浓缩回输治疗乙肝肝硬化腹水的疗效观察[J].中国现代药物应用，2015，9（22）：121-122.
[4]	丁竞高.柔肝化纤方联合腹水超滤浓缩回输术治疗肝硬化腹水的临床体会[J].中国处方药，2015，13（4）：51-52.
[5]	周海霞.腹水浓缩回输联合中药外敷治疗肝硬化腹水的护理体会[J].光明中医，2015，30（10）：2219-2220.
[6]	张凤英.恩替卡韦联合腹水浓缩回输治疗乙肝肝硬化腹水的疗效观察[J].中国现代药物应用，2015，9（22）：121-122.
[8]	施春华.肝硬化腹水患者行自体腹水回输的护理[J].中外医学研究，2012，10（20）：97.
[9]	刘婷婷.腹水直接浓缩回输治疗肝硬化腹水的护理体会[J].中国中医药现代远程教育，2012，10（18）：122-123.
[10]	何灏澜.肝硬化腹水浓缩回输术后腹腔内注射抑肽酶减少腹腔内粘连临床观察[J].中外医疗，2014，33（4）：47-48.
[7]	Singh N，Sifri C D,Silveira FP，et al.Cryptococcosis in patients with cirrhosis of the liver and posttransplant outcomes[J]. Transplantation，2015，Online First（10）：2132-2141.
[11]	刘超英.腹水超滤浓缩技术应用研究[J].中国医学装备，2013，10（12）：105-107.
[12]	毛鸿琴，杨玲燕，陆霞.腹水超滤浓缩腹腔回输治疗肝硬化腹水的疗效观察及护理[J].宁夏医学杂志，2014，36（11）：1081-1082.
[13]	詹建生，陈淑娜.超滤浓缩回输对肝硬化腹水患者自然杀伤T细胞及RAAS系统的影响[J].现代消化及介入诊疗，2012，17（3）：133-137.
[14]	李德勤，费永秀.肝硬化腹水患者行超滤浓缩腹水回输术的效果及护理[J].中华现代护理杂志，2012，18（21）：2552-2554.
[15]	温新兰，刘小静，彭桂莲.肝硬化腹水超滤浓缩回输术的护理体会[J].内蒙古中医药，2012，31（4）：174-175